期刊文献+

Favorable outcomes of hilar duct oriented hepatic resection for high grade Tsunoda type hepatolithiasis 被引量:35

Favorable outcomes of hilar duct oriented hepatic resection for high grade Tsunoda type hepatolithiasis
下载PDF
导出
摘要 瞄准:评估门管的功效为难处理的肝石病的面向的肝切除术,被作者使用了的腹的核暴露(VHE ) 方法。方法:从 1994 年 6 月到为 10 年的一个时期的 2004 年 6 月,有 Tsunoda 的 153 个病人打 III 或 IV 肝石病,在我们的机构的收到的肝切除术。在这些病人之中, 128 由 VHE 方法经历了肝切除术的人,是为学习的题目。我们分析了这个过程, intra 肝的石头的剩余率,和石头的风险周期性的率。结果:平均年龄是 54.2 年,并且到女比率的男性是 1:1.7。平均后续时期是 25.6 瞬间(6-114 瞬间) 。在操作以后没有手术后的严重复杂并发症或死亡。剩余石头的率是 5.4% ,周期性的石头的率是 4.2% 。结论:VHE 是一个安全外科的过程并且提供难处理的肝石病的有利治疗结果。特别,这个过程有优点因为 intra 肝的胆汁管苛评可以在外科期间直接被证实并且改正。 AIM: To evaluate the efficacy of hilar duct oriented hepatectomy for intractable hepatolithiasis, the ventral hilum exposure (VHE) method that has been applied by the authors. METHODS: From June 1994 to June 2004 for a period of 10 years, 153 patients who had Tsunoda type Ⅲ or Ⅳ hepatolithiasis, received hepatectomy at our institution. Among these patients, 128 who underwent hepatectomy by the VHE method were the subjects for the study. We analyzed the risk of this procedure, residual rate of intrahepatic stones, and stone recurrent rates. RESULTS: The average age was 54.2 years, and the male to female ratio was 1:1.7. The average follow-up period was 25.6 mo (6-114 too). There was no postoperative severe complication or mortality after the operation. The rate of residual stones was 5.4% and the rate of recurrent stones was 4.2%. CONCLUSION: VHE is a safe surgical procedure and provides favorable treatment results of intractable hepatolithiasis. Especially, this procedure has advantage in that intra-hepatic bile duct stricture may be confirmed and corrected directly during surgery.
机构地区 Department of Surgery
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第3期431-436,共6页 世界胃肠病学杂志(英文版)
关键词 肝切除术 胆石疾病 治疗 临床表现 Hepatolithiasis Hepatic resection Residual stone Recurrent stone
  • 相关文献

参考文献25

  • 1[1]Chen MF,Jan YY,Wang CS,Hwang TL,Jeng LB,Chen SC,Chen TJ.A reappraisal of cholangiocarcinoma in patient with hepatolithiasis.Cancer 1993;71:2461-2465
  • 2[2]Kubo S,Kinoshita H,Hirohashi K,Hamba H.Hepatolithiasis associated with cholangiocarcinoma.World J Surg 1995;19:637-641
  • 3[3]Park YH,Park SJ,Jang JY,Ahn YJ,Park YC,Yoon YB,Kim SW.Changing patterns of gallstone disease in Korea.World J Surg 2004;28:206-210
  • 4[4]Cetta F,Lombardo F,Cariati A.The role of the content (decreased level of apolipoprotein A1) and of the container (bile duct stricture,sectorial dilatation of the ducts determining bile stasis) in the pathogenesis of hepatolithiasis,either pigment or cholesterol.Hepatology 1994;19:1539-1541
  • 5[5]Nakanuma Y,Yamaguchi K,Ohta G,Terada T.Pathologic features of hepatolithiasis in Japan.Hum Pathol 1988;19:1181-1186
  • 6[6]Hwang JH,Yoon YB,Kim YT,Cheon JH,Jeong JB.Risk factors for recurrent cholangitis after initial hepatolithiasis treatment.J Clin Gastroenterol 2004;38:364-367
  • 7[7]Maetani I,Ishiguro J,Ogawa S,Sato M,Igarashi Y,Sakai Y.Percutaneous choledochoscopic treatment of intrahepatic stones,including management of associated biliary stenoses.Endoscopy 1999;31:456-459
  • 8[8]Uchiyama K,Onishi H,Tani M,Kinoshita H,Ueno M,Yamaue H.Indication and procedure for treatment of hepatolithiasis.Arch Surg 2002;137:149-153
  • 9[9]Cheung MT,Wai SH,Kwok PC.Percutaneous transhepatic choledochoscopic removal of intrahepatic stones.Br J Surg2003;90:1409-1415
  • 10[10]Tsunoda T,Tsuchiya R,Harada N,Yoshino R,Noda T,Izawa K,Yamaguchi T,Yamamoto K.Long-term results of surgical treatment for intrahepatic stones.Jpn J Surg 1985;15:455-462

同被引文献198

引证文献35

二级引证文献268

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部